Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	237.94	231.4	249.55	219.15	126.35
Short-Term Investments	-	1,176	1,167	384.44	1,130	490.29
Trading Asset Securities	-	-	5.57	49.6	-	-
Cash & Short-Term Investments	1,413	1,413	1,404	683.59	1,349	616.64
Cash Growth	0.70%	0.70%	105.34%	-49.34%	118.83%	55.25%
Accounts Receivable	-	4,384	4,043	3,852	3,928	4,638
Other Receivables	-	120.06	134.02	57.8	119.38	170.47
Receivables	-	4,504	4,178	3,910	4,048	4,810
Inventory	-	1,257	1,184	1,031	1,239	989.27
Prepaid Expenses	-	24.7	27.76	24.21	31.9	14.32
Other Current Assets	-	1,066	1,315	1,325	1,100	1,222
Total Current Assets	-	8,265	8,109	6,974	7,769	7,652
Property, Plant & Equipment	-	4,177	3,694	3,729	2,948	2,278
Long-Term Investments	-	310.67	80.2	568.59	36.75	620.13
Goodwill	-	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	-	2.3	1.07	2.29	3.83	5.79
Long-Term Deferred Tax Assets	-	-	-	33.33	-	-
Other Long-Term Assets	-	176.06	154.99	184.42	252.93	134.35
Total Assets	-	13,008	12,116	11,569	11,087	10,768
Accounts Payable	-	714.18	609.65	863.9	926.06	742.25
Accrued Expenses	-	96.8	64.46	55.09	47.86	50.93
Short-Term Debt	-	232.16	324.17	460.14	607.03	650.38
Current Portion of Long-Term Debt	-	279.13	197.98	113.63	210.32	211.11
Current Portion of Leases	-	44.1	27.55	11.14	9.42	13.18
Current Income Taxes Payable	-	37.74	18.66	26.56	66.49	86.01
Current Unearned Revenue	-	45.7	69.24	34.7	90.08	157.91
Other Current Liabilities	-	267.36	262.36	367.44	373.6	124.59
Total Current Liabilities	-	1,717	1,574	1,933	2,331	2,036
Long-Term Debt	-	198.46	355.92	406.9	232.22	326.04
Long-Term Leases	-	127.19	92.79	27.17	34.92	18.29
Long-Term Unearned Revenue	-	0.47	0.61	0.74	0.87	1.01
Long-Term Deferred Tax Liabilities	-	3	35.93	-	13.23	82.09
Total Liabilities	-	2,090	2,086	2,394	2,623	2,489
Common Stock	-	105.37	104.69	104.15	103.68	103.15
Additional Paid-In Capital	-	404.24	331.64	269.94	212.77	147.57
Retained Earnings	-	10,120	9,324	8,603	7,941	7,826
Comprehensive Income & Other	-	-126.06	-88.46	-138.53	-70.73	5.38
Total Common Equity	10,504	10,504	9,672	8,839	8,187	8,083
Minority Interest	-	414.71	357.9	335.27	277.6	196.56
Shareholders' Equity	10,918	10,918	10,030	9,174	8,465	8,279
Total Liabilities & Equity	-	13,008	12,116	11,569	11,087	10,768
Total Debt	881.04	881.04	998.4	1,019	1,094	1,219
Net Cash (Debt)	532.41	532.41	405.27	-335.39	255.5	-602.36
Net Cash Growth	31.37%	31.37%	-	-	-	-
Net Cash Per Share	5.03	5.02	3.82	-3.18	2.43	-5.71
Filing Date Shares Outstanding	105.49	105.37	104.69	104.15	103.68	103.36
Total Common Shares Outstanding	105.49	105.37	104.69	104.15	103.68	103.15
Working Capital	-	6,548	6,535	5,041	5,438	5,616
Book Value Per Share	99.68	99.68	92.39	84.87	78.97	78.36
Tangible Book Value	10,424	10,424	9,594	8,760	8,106	8,000
Tangible Book Value Per Share	98.93	98.93	91.64	84.10	78.19	77.56
Land	-	422.36	409.88	419.83	420.09	144.14
Buildings	-	1,360	1,369	1,437	1,059	1,055
Machinery	-	3,152	2,616	2,580	1,809	1,490
Construction In Progress	-	207.11	78.27	28.01	221.55	23.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.